Articles

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for...

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience environment of healthcare reform, there needs to be a clear, quantifiable...

Mr. KH is a 58-year-old male with a past medical history of hypertension and tobacco abuse who presented to the  emergency department (ED) with an episode of syncope. The patient stated that...

Infraredx Inc. Prospect II Clinical Trial Intravascular Imaging System

Infraredx Inc. announced the first patient enrolled in PROSPECT II, a multi-center, prospective study designed to assess the ability of intravascular imaging to identify non-flow obstructing...

The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last...

Sonivate

More than 55 companies displayed their latest products and services at the American Society of Echocardiography (ASE) 25th Annual Scientific Sessions June 20-24 in Portland, Ore. The meeting is...

LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk.

Researchers have announced the results of a study that used a novel echocardiographic technique to detect and quantify damage to heart muscle even after an episode of mild cardiac injury from...

June 18, 2014 — Researchers at Sandia National Laboratories, along with collaborators from Rice University and the Tokyo Institute of Technology, are developing new terahertz detectors based on...

Sapien XT, FDA

The U.S. Food and Drug Administration (FDA) approval for its Edwards Sapien XT transcatheter aortic heart valve for the treatment of high-risk and inoperable patients suffering from severe...